MarketInOut Stock Screener Log In | Sign Up

China Health Group Inc

HKSE • Healthcare • Diagnostics & Research • Quote as of 10/28/2026
China Health Group Inc stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeHKSE
Market Capitalization68.68 mln
Float298 mln
Earnings Date03/30/2027

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-4.33
Highly reliable

Relative Strength

5 / 100
Severely lagging

Pre-Tax Margin

-44%
Deeply loss-making

ROE

-20.26
Deeply negative

Altman Z-Score

0.31
Distressed

Business Description

Founded in 1998 and based in Beijing, China Health Group Inc. develops both natural and synthetic pharmaceutical products for the Chinese market. The company conducts drug research, supports clinical studies, and offers development services to other pharmaceutical businesses. It has operated under its current name since 2015.

Key Fundamentals

EPS-0.02
ROE-20.26
RPS0.05
ROIC-37.91
ROA-13.63
Interest Cover4,956
EBITDA, mln-14.85
EV / EBITDA-2.48
EV / EBIT-2.48
Revenue, mln33.77
EV / Revenue1.09

Quote Details

Last 0.063
Change 0 (0%)
Open 0.063
Volume 20,000
Turnover 1,260
Average Volume 273,331

Financial Ratios

Pre-Tax Profit Margin-44
Leverage Ratio1.53
Current Ratio2.55
Price / Book0.99
Price / Tangible Book0.99
Price / Cash Flow20.69
Price / Free Cash Flow5.64
Price / Sales2.32

Financial Strength

Altman Z-Score0.31
Piotroski F-Score 6 / 9
Beneish M-Score-4.33
Price to Intrinsic Value1.13
Shiller PE Ratio7.90

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -20.25% 2 / 100   
1 Month -33.68% 4 / 100   
2 Months -56.85% 2 / 100   
6 Months -58.82% 7 / 100   
1 Year -68.34% 7 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog